The distribution of vasoactive intestinal peptide binding sites in the rat brain was examined by in vitro autoradiography on slide-mounted sections. A fully characterized monoiodinated form of vasoactive intestinal peptide (M-[125I]VIP) previously shown to maintain in the central nervous system the full biological activity of native vasoactive intestinal peptide was used for this study. In initial kinetic and pharmacological experiments the binding of M-[125I]vasoactive intestinal peptide to slide-mounted sections was shown to be time-dependent, saturable and reversible. Association of M-[125I]VIP specific binding was maximal within 90-120 minutes. Specific binding, corresponding to approximately 50% of total binding was saturable, of high ...
The binding characteristics of a monoiodinated form of vasoactive intestinal peptide (M-[125I]VIP) t...
The aim of this work was to study in rats the nasal route for the brain delivery of the vasoactive i...
Vasoactive intestinal polypeptide (VIP) was labeled with sodium [125I]iodide using the chloramine-T ...
The distribution of vasoactive intestinal peptide binding sites in the rat brain was examined by in ...
The distribution of vasoactive intestinal peptide binding sites in the rat brain was examined by in ...
1. Localization and pharmacological properties of the vasoactive intestinal polypeptide (VIP) recept...
1. Localization and pharmacological properties of the vasoactive intestinal polypeptide (VIP) recept...
1. Localization and pharmacological properties of the vasoactive intestinal polypeptide (VIP) recept...
The distribution of vasoactive intestinal peptide (VIP) binding sites in the brain of several verteb...
The distribution of vasoactive intestinal peptide (VIP) binding sites in the brain of several verteb...
By the use of combined in vitro radioreceptor binding and autoradiographic techniques, we analyzed t...
By the use of combined in vitro radioreceptor binding and autoradiographic techniques, we analyzed t...
The distribution of VIP binding sites in rat kidney and adrenal gland has been examined by light mic...
The distribution of VIP binding sites in rat kidney and adrenal gland has been examined by light mic...
The distribution of VIP binding sites in rat kidney and adrenal gland has been examined by light mic...
The binding characteristics of a monoiodinated form of vasoactive intestinal peptide (M-[125I]VIP) t...
The aim of this work was to study in rats the nasal route for the brain delivery of the vasoactive i...
Vasoactive intestinal polypeptide (VIP) was labeled with sodium [125I]iodide using the chloramine-T ...
The distribution of vasoactive intestinal peptide binding sites in the rat brain was examined by in ...
The distribution of vasoactive intestinal peptide binding sites in the rat brain was examined by in ...
1. Localization and pharmacological properties of the vasoactive intestinal polypeptide (VIP) recept...
1. Localization and pharmacological properties of the vasoactive intestinal polypeptide (VIP) recept...
1. Localization and pharmacological properties of the vasoactive intestinal polypeptide (VIP) recept...
The distribution of vasoactive intestinal peptide (VIP) binding sites in the brain of several verteb...
The distribution of vasoactive intestinal peptide (VIP) binding sites in the brain of several verteb...
By the use of combined in vitro radioreceptor binding and autoradiographic techniques, we analyzed t...
By the use of combined in vitro radioreceptor binding and autoradiographic techniques, we analyzed t...
The distribution of VIP binding sites in rat kidney and adrenal gland has been examined by light mic...
The distribution of VIP binding sites in rat kidney and adrenal gland has been examined by light mic...
The distribution of VIP binding sites in rat kidney and adrenal gland has been examined by light mic...
The binding characteristics of a monoiodinated form of vasoactive intestinal peptide (M-[125I]VIP) t...
The aim of this work was to study in rats the nasal route for the brain delivery of the vasoactive i...
Vasoactive intestinal polypeptide (VIP) was labeled with sodium [125I]iodide using the chloramine-T ...